Showing 1111-1120 of 2689 results for "".
Fibromuscular Dysplasia and Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/fibromuscular-dysplasia-and-stroke/31615/Stroke in fibromuscular dysplasia is associated with cervical artery dissection and can be managed with antiplatelet therapy and avoidance of high-risk cervical exertion.Inpatient Rehabilitation Following Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/inpatient-rehabilitation-following-traumatic-brain-injury/31989/Unique care and benefits of inpatient rehabilitation facilities compared with other care settingsPompe Disease
https://practicalneurology.com/diseases-diagnoses/child-neurology/pompe-disease/31686/New treatments, available and in development, underscore need for high degree of suspicion for Pompe disease in differential for weakness and respiratory difficulties.Stroke Snapshot: Cerebral Microinfarcts—Etiology and Clinical Implications of This Novel MRI Marker
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-cerebral-microinfarcts-etiology-and-clinical-implications-of-this-novel-mri-marker/32105/Cerebral microinfarcts—microscopic brain lesions of ischemic origin—have been linked to cerebral small vessel disease, microemboli, cerebral hypoperfusion, cognitive decline, and poor clinical outcome.Stroke Snapshot: Platelet Function Testing in Ischemic Stroke and Transient Ischemic Attack
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-platelet-function-testing-in-ischemic-stroke-and-transient-ischemic-attack/32146/Platelet function testing allows antiplatelet regimens to be tailored more effectively for individuals with ischemic stroke or TIA, and an understanding of antiplatelet pharmacokinetics is essential to its implementation.Dementia Insights: Antiamyloid Antibody Therapy in Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-antiamyloid-antibody-therapy-in-alzheimer-disease/31928/The saga continues for development of antiamyloid monoclonal antibodies, aducanumab, lecanemab, donanemab, and gantenerumab for Alzheimer disease.Understanding Chiari Malformations
https://practicalneurology.com/diseases-diagnoses/headache-pain/understanding-chiari-malformations/31916/Part I of this special report reviews the pathogenesis, classification, presentation, and diagnosis of Chiari malformations.Epilepsy Essentials: Novel Interictal Biomarkers for Delineating the Epileptogenic Zone in Children With Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-novel-interictal-biomarkers-for-delineating-the-epileptogenic-zone-in-children-with-drug-resistant-epilepsy/32147/Novel interictal biomarkers of epilepsy are able to identify the epileptogenic zone with precision and predict surgical outcome in children with drug-resistant epilepsy.Sphingosine-1-Phosphate Modulators for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/sphingosine-1-phosphate-modulators-for-multiple-sclerosis/31629/Sphingosine-1-phosphate modulators may act through more than just inhibition of neuroimmune and neuroinflammatory effects of multiple sclerosis.Atrial Cardiopathy and Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/atrial-cardiopathy-and-stroke/31614/The past decade there has been a resurgence in understanding of the relationship of atrial fibrillation to stroke.